Skip to main
CI

Cigna (CI) Stock Forecast & Price Target

Cigna (CI) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 28%
Buy 50%
Hold 22%
Sell 0%
Strong Sell 0%

Bulls say

Cigna Group is a diversified global health service company that primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its recently completed merger with Express Scripts, are mainly sold to health insurance plans and employers. The company's strong financial performance is driven by its growing specialty and care services division, as well as its focus on cost management and strategic initiatives such as exiting the individual Affordable Care Act exchange market. In addition, Cigna's commitment to diversity and sustainability may appeal to socially responsible investors.

Bears say

Cigna Group is facing pressure from its underperforming pharmacy benefit management and health insurance services segments, which are expected to continue underperforming in the near future. The company's recent attempts to expand its PBM business through acquisitions and contracts have not translated into significant growth, leading to concerns about its ability to compete against larger players in the market. Additionally, the decision to exit the individual health insurance market in 2027 may cause short-term losses, but is a smart long-term move to focus on its more profitable core business lines.

Cigna (CI) has been analyzed by 18 analysts, with a consensus rating of Buy. 28% of analysts recommend a Strong Buy, 50% recommend Buy, 22% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cigna (CI) Forecast

Analysts have given Cigna (CI) a Buy based on their latest research and market trends.

According to 18 analysts, Cigna (CI) has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $344.61, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $344.61, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cigna (CI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.